![[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!](https://businessfortnight.com/wp-content/uploads/2025/10/Toyota-Times-Century-as-a-Brand-Lexus-as-Innovation-All-218x150.jpg "[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!")
MORRISVILLE, N.C., Nov. 01, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) introduced as we speak that it’ll report its third quarter 2022 monetary outcomes on Tuesday, November 8, 2022. The firm will host a convention name and webcast at 8:30 a.m. Eastern Time to focus on monetary outcomes and supply a company replace.
The reside name could also be accessed by dialing 1-800-715-9871 (home) or 1-646-307-1963 (worldwide) and getting into the convention code: 7467713. A webcast of the decision will probably be obtainable and archived for 30 days on Liquidia’s web site at https://liquidia.com/index.php/investors/events-and-presentations.
About Liquidia Corporation
Liquidia Corporation is a biopharmaceutical firm targeted on the event and commercialization of merchandise in pulmonary hypertension and different functions of its PRINT® Technology. The firm operates by means of its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA™ (treprostinil) inhalation powder, an investigational, inhaled dry powder formulation of treprostinil for the therapy of pulmonary arterial hypertension (PAH). Liquidia PAH offers the commercialization for uncommon illness pharmaceutical merchandise, similar to generic Treprostinil Injection. For extra data, please go to www.liquidia.com.
Contact Information for Media & Investors
Jason Adair
Senior Vice President, Corporate Development and Strategy
919.328.4400
[email protected]
